Simon N.R.  Harford net worth and biography

Simon Harford Biography and Net Worth

Simon Harford joined Albireo in October 2018 as Chief Financial Officer following many years of finance experience in the pharmaceutical and healthcare industry both in the U.S and internationally.  Simon was most recently SVP and Chief Financial Officer at PAREXEL International Corporation, a leading global clinical research organization, where he led the financial aspects of the transition from public to private-equity owned company. Previously, Simon spent 8 years at GlaxoSmithKline plc based in their global headquarters outside London culminating in his role as SVP Finance, Global Pharmaceuticals with responsibility for the finance function of the global pharmaceutical business. Earlier in his career, he spent 20 years at Eli Lilly and Company in numerous senior leadership roles in the U.S. and Europe including Head of Investor Relations, European CFO and as Corporate Controller. Simon has an MBA from the University of Virginia’s Darden School of Business.

How do I contact Simon N.R. Harford?

The corporate mailing address for Mr. Harford and other Albireo Pharma executives is 10 POST OFFICE SQUARE SUITE 502 SOUTH, BOSTON MA, 02109. Albireo Pharma can also be reached via phone at (857) 254-5555 and via email at [email protected]. Learn More on Simon N.R. Harford's contact information.

Has Simon N.R. Harford been buying or selling shares of Albireo Pharma?

Simon N.R. Harford has not been actively trading shares of Albireo Pharma within the last three months. Learn More on Simon N.R. Harford's trading history.

Who are Albireo Pharma's active insiders?

Albireo Pharma's insider roster includes Ronald Cooper (CEO), Jason Duncan (Insider), Simon Harford (CFO), Patrick Horn (Insider), Jan Mattsson (Insider), and Pamela Stephenson (insider). Learn More on Albireo Pharma's active insiders.

Simon N.R. Harford Insider Trading History at Albireo Pharma

See Full Table

Simon N.R. Harford Buying and Selling Activity at Albireo Pharma

This chart shows Simon N.R. Harford's buying and selling at Albireo Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Albireo Pharma Company Overview

Albireo Pharma logo
Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.
Read More

Today's Range

Now: $44.15
Low: $43.99
High: $44.90

50 Day Range

MA: $44.17
Low: $43.50
High: $44.95

2 Week Range

Now: $44.15
Low: $16.02
High: $45.23

Volume

1,241,200 shs

Average Volume

704,539 shs

Market Capitalization

$913.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03